These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7656243

  • 1. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV, Xu BH, Gupta V, Emerson EO, Zaren HA, Jani JP.
    Cancer Lett; 1995 Aug 16; 95(1-2):49-56. PubMed ID: 7656243
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
    Xu BH, Gupta V, Singh SV.
    Br J Cancer; 1994 Feb 16; 69(2):242-6. PubMed ID: 8297721
    [Abstract] [Full Text] [Related]

  • 3. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line].
    Xu B, Sun Y, Singh SV.
    Zhonghua Zhong Liu Za Zhi; 1995 Sep 16; 17(5):343-6. PubMed ID: 8697971
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
    Xu BH, Gupta V, Singh SV.
    Int J Cancer; 1994 Sep 01; 58(5):686-92. PubMed ID: 8077054
    [Abstract] [Full Text] [Related]

  • 5. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 6. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA, Kang Y, Greaves B, Perry RR.
    J Surg Res; 1998 Dec 01; 80(2):177-81. PubMed ID: 9878310
    [Abstract] [Full Text] [Related]

  • 7. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 01; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 8. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Scalamogna D, Xia H, O'Toole S, Roy D, Emerson EO, Gupta V, Zaren HA.
    Int J Cancer; 1996 Mar 15; 65(6):852-7. PubMed ID: 8631603
    [Abstract] [Full Text] [Related]

  • 9. Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions.
    Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson ID.
    Cancer Res; 1990 Aug 01; 50(15):4692-7. PubMed ID: 2114946
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a BMS-181174-resistant human bladder cancer cell line.
    Xia H, Bleicher RJ, Hu X, Srivastava SK, Gupta V, Zaren HA, Singh SV.
    Br J Cancer; 1997 Aug 01; 76(4):461-6. PubMed ID: 9275022
    [Abstract] [Full Text] [Related]

  • 11. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
    Singh SV, Xu BH, Maurya AK, Mian AM.
    Biochim Biophys Acta; 1992 Nov 17; 1137(3):257-63. PubMed ID: 1445927
    [Abstract] [Full Text] [Related]

  • 12. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH, Naito M, Nakajima M, Tsuruo T.
    Cancer Chemother Pharmacol; 1993 Nov 17; 33(3):215-20. PubMed ID: 7505723
    [Abstract] [Full Text] [Related]

  • 13. [DT-diaphorase].
    Mikami K, Shirakusa T, Tsuruo T.
    Gan To Kagaku Ryoho; 1997 Sep 17; 24(11):1606-10. PubMed ID: 9309161
    [Abstract] [Full Text] [Related]

  • 14. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
    Willson JK, Long BH, Chakrabarty S, Brattain DE, Brattain MG.
    Cancer Res; 1985 Nov 17; 45(11 Pt 1):5281-6. PubMed ID: 3931904
    [Abstract] [Full Text] [Related]

  • 15. Molecular targeting of mitomycin C chemotherapy.
    Nishiyama M, Suzuki K, Kumazaki T, Yamamoto W, Toge T, Okamura T, Kurisu K.
    Int J Cancer; 1997 Aug 07; 72(4):649-56. PubMed ID: 9259406
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Xu BH, Jani JP, Emerson EO, Backes MG, Rihn C, Scalamogna D, Stemmler N, Specht S, Blanock K.
    Int J Cancer; 1995 May 04; 61(3):431-6. PubMed ID: 7729958
    [Abstract] [Full Text] [Related]

  • 17. Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.
    Bando T, Kasahara K, Shibata K, Numata Y, Heki U, Shirasaki H, Iwasa K, Fujimura M, Matsuda T.
    J Cancer Res Clin Oncol; 1996 May 04; 122(1):21-6. PubMed ID: 8543588
    [Abstract] [Full Text] [Related]

  • 18. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
    Gan Y, Mo Y, Kalns JE, Lu J, Danenberg K, Danenberg P, Wientjes MG, Au JL.
    Clin Cancer Res; 2001 May 04; 7(5):1313-9. PubMed ID: 11350900
    [Abstract] [Full Text] [Related]

  • 19. Regulatory network of mitomycin C action in human colon cancer cells.
    Suzuki K, Yamamoto W, Park JS, Hanaoka H, Okamoto R, Kirihara Y, Yorishima T, Okamura T, Kumazaki T, Nishiyama M.
    Jpn J Cancer Res; 1999 May 04; 90(5):571-7. PubMed ID: 10391098
    [Abstract] [Full Text] [Related]

  • 20. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
    O'Dwyer PJ, Perez RP, Yao KS, Godwin AK, Hamilton TC.
    Biochem Pharmacol; 1996 Jul 12; 52(1):21-7. PubMed ID: 8678904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.